NASDAQ$BTTC

Black Titan Corp · Q3 2020 earnings

Q3 2020 earnings · · Investor relations

Headline financials

Total Revenue

$47.1K

Previous: $83K-43.2%
EPS (adj)

-$30.00

Previous: -$108.00+72.2%
Net Income

-$80.4K

Previous: -$687K+88.3%
Operating Income

-$74.8K

Previous: -$672K+88.9%
Gross Profit

$47.1K

Previous: -$6.51K+823.7%
Cash & Equivalents

$56.3K

Previous: $189K-70.3%
Total Assets

$420K

Previous: $1.71M-75.4%

Revenue & EPS history

Titan Pharmaceuticals · Revenue · Quarterly

$47.1K

Q3 2020-43.2%vs Q3 2019
Beat estimate in 3 of 14 quarters(21%)
ActualEstimate

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro